| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Injuries, Traumatic | 20 | 2023 | 86 | 10.800 |
Why?
|
| Brain Injuries | 24 | 2023 | 161 | 9.640 |
Why?
|
| Intracranial Hypertension | 15 | 2021 | 48 | 7.120 |
Why?
|
| Cerebrovascular Circulation | 16 | 2023 | 212 | 5.470 |
Why?
|
| Intracranial Pressure | 17 | 2023 | 77 | 5.330 |
Why?
|
| Head Injuries, Penetrating | 8 | 2023 | 54 | 5.040 |
Why?
|
| Brain Death | 8 | 2022 | 69 | 4.240 |
Why?
|
| Tissue and Organ Procurement | 7 | 2023 | 311 | 3.570 |
Why?
|
| Monitoring, Physiologic | 12 | 2023 | 268 | 3.200 |
Why?
|
| Consciousness | 4 | 2023 | 26 | 2.680 |
Why?
|
| Tissue Donors | 7 | 2023 | 463 | 2.670 |
Why?
|
| Decompressive Craniectomy | 5 | 2023 | 18 | 2.670 |
Why?
|
| Critical Care | 15 | 2023 | 370 | 2.660 |
Why?
|
| Brain | 15 | 2023 | 2216 | 2.420 |
Why?
|
| Clinical Decision-Making | 4 | 2021 | 257 | 2.400 |
Why?
|
| Cerebral Hemorrhage | 11 | 2022 | 325 | 2.270 |
Why?
|
| Death | 6 | 2023 | 73 | 2.070 |
Why?
|
| Hypoxia, Brain | 4 | 2023 | 41 | 1.990 |
Why?
|
| Consciousness Disorders | 3 | 2023 | 9 | 1.960 |
Why?
|
| Humans | 110 | 2023 | 86601 | 1.800 |
Why?
|
| Intensive Care Units | 10 | 2023 | 373 | 1.550 |
Why?
|
| Subarachnoid Hemorrhage | 6 | 2012 | 137 | 1.520 |
Why?
|
| Hematoma | 2 | 2021 | 104 | 1.460 |
Why?
|
| Mental Competency | 2 | 2023 | 49 | 1.400 |
Why?
|
| Coma | 4 | 2023 | 44 | 1.350 |
Why?
|
| Metaphysics | 2 | 2021 | 3 | 1.310 |
Why?
|
| Brain Edema | 3 | 2021 | 50 | 1.270 |
Why?
|
| Apnea | 2 | 2020 | 29 | 1.260 |
Why?
|
| Brain Ischemia | 6 | 2021 | 398 | 1.240 |
Why?
|
| Hemostatics | 2 | 2021 | 56 | 1.210 |
Why?
|
| Perfusion | 5 | 2023 | 203 | 1.140 |
Why?
|
| Neurophysiological Monitoring | 6 | 2016 | 11 | 1.120 |
Why?
|
| Vasospasm, Intracranial | 4 | 2010 | 36 | 1.110 |
Why?
|
| Hypothermia, Induced | 2 | 2016 | 74 | 1.090 |
Why?
|
| Stroke | 8 | 2021 | 965 | 1.020 |
Why?
|
| Arterial Pressure | 2 | 2014 | 38 | 0.970 |
Why?
|
| Elephants | 1 | 2023 | 16 | 0.930 |
Why?
|
| Patient Preference | 2 | 2021 | 105 | 0.900 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 864 | 0.900 |
Why?
|
| Informed Consent | 4 | 2023 | 266 | 0.890 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2023 | 148 | 0.880 |
Why?
|
| Spinal Cord Injuries | 2 | 2014 | 54 | 0.870 |
Why?
|
| Practice Guidelines as Topic | 4 | 2021 | 1034 | 0.840 |
Why?
|
| Wounds, Gunshot | 2 | 2020 | 71 | 0.840 |
Why?
|
| Decision Making | 4 | 2023 | 642 | 0.830 |
Why?
|
| Oxygen Consumption | 3 | 2023 | 239 | 0.820 |
Why?
|
| Withholding Treatment | 3 | 2021 | 112 | 0.810 |
Why?
|
| Injury Severity Score | 2 | 2021 | 111 | 0.800 |
Why?
|
| Uncertainty | 2 | 2019 | 71 | 0.800 |
Why?
|
| Hypoxia | 2 | 2016 | 641 | 0.800 |
Why?
|
| Judgment | 1 | 2022 | 64 | 0.790 |
Why?
|
| Length of Stay | 4 | 2023 | 700 | 0.790 |
Why?
|
| Vascular System Injuries | 1 | 2021 | 29 | 0.790 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 2021 | 12 | 0.780 |
Why?
|
| Cognitive Dysfunction | 1 | 2023 | 132 | 0.780 |
Why?
|
| Disabled Persons | 1 | 2021 | 67 | 0.770 |
Why?
|
| Hypocalcemia | 1 | 2020 | 41 | 0.770 |
Why?
|
| Heart Conduction System | 1 | 2021 | 108 | 0.760 |
Why?
|
| Communication | 3 | 2023 | 440 | 0.760 |
Why?
|
| Ventilator Weaning | 2 | 2011 | 24 | 0.760 |
Why?
|
| Oxygen | 5 | 2023 | 726 | 0.750 |
Why?
|
| Critical Illness | 4 | 2017 | 294 | 0.750 |
Why?
|
| Amantadine | 1 | 2020 | 18 | 0.750 |
Why?
|
| Nootropic Agents | 1 | 2020 | 10 | 0.740 |
Why?
|
| Neurosurgical Procedures | 5 | 2023 | 213 | 0.740 |
Why?
|
| Respiration, Artificial | 2 | 2021 | 334 | 0.730 |
Why?
|
| Blood Coagulation Disorders | 1 | 2021 | 63 | 0.720 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2021 | 134 | 0.710 |
Why?
|
| Life Support Care | 2 | 2021 | 49 | 0.710 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 187 | 0.710 |
Why?
|
| Prognosis | 10 | 2021 | 3674 | 0.690 |
Why?
|
| Recovery of Function | 3 | 2020 | 272 | 0.690 |
Why?
|
| Electrocardiography | 1 | 2021 | 478 | 0.670 |
Why?
|
| Glasgow Coma Scale | 5 | 2023 | 65 | 0.660 |
Why?
|
| Heart Rate | 1 | 2021 | 492 | 0.660 |
Why?
|
| Cognition Disorders | 1 | 2020 | 236 | 0.640 |
Why?
|
| Intracranial Aneurysm | 3 | 2020 | 158 | 0.620 |
Why?
|
| Family | 2 | 2017 | 311 | 0.620 |
Why?
|
| Craniocerebral Trauma | 2 | 2020 | 52 | 0.620 |
Why?
|
| Pleasure-Pain Principle | 1 | 2017 | 2 | 0.620 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 763 | 0.610 |
Why?
|
| Action Potentials | 1 | 2021 | 573 | 0.610 |
Why?
|
| Seizures | 1 | 2020 | 295 | 0.600 |
Why?
|
| Male | 30 | 2023 | 40956 | 0.600 |
Why?
|
| Workload | 1 | 2018 | 128 | 0.600 |
Why?
|
| Terminal Care | 1 | 2018 | 130 | 0.600 |
Why?
|
| Retrospective Studies | 17 | 2023 | 8475 | 0.600 |
Why?
|
| Suicide, Assisted | 1 | 2017 | 31 | 0.600 |
Why?
|
| Patient Advocacy | 1 | 2017 | 49 | 0.600 |
Why?
|
| Heart Arrest | 2 | 2023 | 265 | 0.590 |
Why?
|
| Personal Satisfaction | 1 | 2017 | 62 | 0.580 |
Why?
|
| Female | 33 | 2023 | 44507 | 0.580 |
Why?
|
| Shock | 1 | 2016 | 42 | 0.570 |
Why?
|
| Persistent Vegetative State | 1 | 2016 | 9 | 0.570 |
Why?
|
| Saline Solution, Hypertonic | 2 | 2013 | 24 | 0.560 |
Why?
|
| Euthanasia | 1 | 2016 | 16 | 0.560 |
Why?
|
| Mitochondria | 2 | 2016 | 535 | 0.560 |
Why?
|
| Hemodynamics | 3 | 2017 | 710 | 0.540 |
Why?
|
| Middle Aged | 23 | 2023 | 25017 | 0.530 |
Why?
|
| Mind-Body Relations, Metaphysical | 1 | 2015 | 3 | 0.530 |
Why?
|
| Trust | 1 | 2016 | 95 | 0.520 |
Why?
|
| Tissue Survival | 1 | 2015 | 13 | 0.520 |
Why?
|
| Adult | 20 | 2023 | 25640 | 0.520 |
Why?
|
| Lung | 1 | 2021 | 1170 | 0.520 |
Why?
|
| Pyruvic Acid | 1 | 2014 | 12 | 0.510 |
Why?
|
| Social Values | 1 | 2015 | 44 | 0.510 |
Why?
|
| Central Nervous System Infections | 1 | 2014 | 3 | 0.510 |
Why?
|
| Research Design | 2 | 2015 | 594 | 0.510 |
Why?
|
| Lactic Acid | 1 | 2014 | 90 | 0.490 |
Why?
|
| Bioethical Issues | 1 | 2014 | 38 | 0.490 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2014 | 6 | 0.490 |
Why?
|
| Cardiovascular System | 1 | 2015 | 71 | 0.490 |
Why?
|
| Touch | 1 | 2015 | 89 | 0.490 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2015 | 78 | 0.490 |
Why?
|
| Organ Preservation | 3 | 2023 | 83 | 0.490 |
Why?
|
| Aprotinin | 1 | 2013 | 26 | 0.480 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2013 | 3 | 0.470 |
Why?
|
| Intracranial Hypotension | 1 | 2013 | 3 | 0.460 |
Why?
|
| Respiratory Insufficiency | 1 | 2015 | 150 | 0.460 |
Why?
|
| Spinal Cord | 2 | 2014 | 249 | 0.450 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2015 | 139 | 0.450 |
Why?
|
| Hospital Mortality | 2 | 2021 | 348 | 0.440 |
Why?
|
| Hypoglycemia | 1 | 2013 | 107 | 0.440 |
Why?
|
| Treatment Outcome | 11 | 2021 | 7988 | 0.440 |
Why?
|
| Prospective Studies | 9 | 2022 | 4210 | 0.430 |
Why?
|
| Cerebral Angiography | 6 | 2015 | 196 | 0.430 |
Why?
|
| Pulsatile Flow | 1 | 2012 | 49 | 0.430 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 636 | 0.420 |
Why?
|
| Airway Extubation | 1 | 2011 | 13 | 0.410 |
Why?
|
| Risk Assessment | 6 | 2021 | 2261 | 0.400 |
Why?
|
| Tracheostomy | 1 | 2011 | 42 | 0.400 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 581 | 0.400 |
Why?
|
| Physicians | 2 | 2020 | 673 | 0.380 |
Why?
|
| Telemedicine | 2 | 2020 | 169 | 0.380 |
Why?
|
| Heuristics | 2 | 2020 | 15 | 0.380 |
Why?
|
| Cerebral Arteries | 1 | 2010 | 74 | 0.370 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2010 | 78 | 0.360 |
Why?
|
| Shock, Cardiogenic | 1 | 2010 | 94 | 0.350 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2013 | 462 | 0.330 |
Why?
|
| Risk Factors | 7 | 2022 | 5416 | 0.320 |
Why?
|
| Nervous System Diseases | 1 | 2009 | 151 | 0.320 |
Why?
|
| Time Factors | 10 | 2021 | 5209 | 0.320 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2021 | 2600 | 0.310 |
Why?
|
| Cardiomyopathies | 1 | 2010 | 240 | 0.310 |
Why?
|
| Hypernatremia | 1 | 2007 | 9 | 0.300 |
Why?
|
| Predictive Value of Tests | 4 | 2021 | 1673 | 0.300 |
Why?
|
| Emergency Service, Hospital | 2 | 2021 | 484 | 0.290 |
Why?
|
| Thrombolytic Therapy | 3 | 2021 | 220 | 0.290 |
Why?
|
| Giant Cell Arteritis | 1 | 2005 | 5 | 0.280 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2005 | 7 | 0.280 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 469 | 0.270 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 2501 | 0.270 |
Why?
|
| Homeostasis | 2 | 2021 | 409 | 0.260 |
Why?
|
| Young Adult | 4 | 2023 | 5974 | 0.260 |
Why?
|
| Blood Pressure | 2 | 2023 | 1143 | 0.230 |
Why?
|
| Aged | 10 | 2021 | 18402 | 0.230 |
Why?
|
| Regional Blood Flow | 1 | 2023 | 197 | 0.230 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2015 | 162 | 0.220 |
Why?
|
| Comparative Effectiveness Research | 1 | 2023 | 53 | 0.220 |
Why?
|
| Physical Examination | 1 | 2023 | 149 | 0.220 |
Why?
|
| Mortality | 2 | 2020 | 149 | 0.220 |
Why?
|
| Mannitol | 2 | 2013 | 49 | 0.210 |
Why?
|
| Resuscitation | 1 | 2022 | 100 | 0.210 |
Why?
|
| Public Opinion | 1 | 2021 | 43 | 0.210 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2012 | 18 | 0.200 |
Why?
|
| Hypoxia-Ischemia, Brain | 1 | 2021 | 52 | 0.200 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2020 | 4 | 0.200 |
Why?
|
| Hypocapnia | 1 | 2020 | 6 | 0.200 |
Why?
|
| Hypopituitarism | 1 | 2020 | 19 | 0.200 |
Why?
|
| Adrenal Insufficiency | 1 | 2020 | 23 | 0.200 |
Why?
|
| Electrolytes | 1 | 2020 | 52 | 0.190 |
Why?
|
| Tomography Scanners, X-Ray Computed | 3 | 2020 | 20 | 0.190 |
Why?
|
| Clinical Trials as Topic | 3 | 2015 | 1169 | 0.190 |
Why?
|
| Out-of-Hospital Cardiac Arrest | 1 | 2021 | 67 | 0.190 |
Why?
|
| Patient Admission | 1 | 2021 | 112 | 0.190 |
Why?
|
| Triage | 1 | 2021 | 108 | 0.190 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2023 | 190 | 0.190 |
Why?
|
| Qualitative Research | 1 | 2021 | 256 | 0.190 |
Why?
|
| Acute Disease | 4 | 2020 | 826 | 0.190 |
Why?
|
| Spinal Cord Diseases | 2 | 2012 | 29 | 0.180 |
Why?
|
| Prevalence | 2 | 2021 | 1239 | 0.180 |
Why?
|
| Spinal Injuries | 1 | 2020 | 22 | 0.180 |
Why?
|
| Central Nervous System Diseases | 1 | 2020 | 52 | 0.180 |
Why?
|
| Carbon Dioxide | 1 | 2020 | 188 | 0.180 |
Why?
|
| Hypercapnia | 2 | 2020 | 43 | 0.180 |
Why?
|
| Hematologic Diseases | 1 | 2020 | 79 | 0.180 |
Why?
|
| Resource Allocation | 1 | 2020 | 65 | 0.180 |
Why?
|
| Patient Participation | 1 | 2021 | 216 | 0.180 |
Why?
|
| Sodium | 1 | 2020 | 341 | 0.170 |
Why?
|
| Intracranial Hemorrhages | 1 | 2020 | 120 | 0.170 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2020 | 71 | 0.170 |
Why?
|
| Morals | 1 | 2020 | 92 | 0.170 |
Why?
|
| Hypothyroidism | 1 | 2020 | 232 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2020 | 119 | 0.170 |
Why?
|
| Drainage | 1 | 2019 | 157 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2020 | 170 | 0.160 |
Why?
|
| Patient Readmission | 1 | 2022 | 329 | 0.160 |
Why?
|
| Patient Selection | 2 | 2012 | 685 | 0.160 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 6501 | 0.160 |
Why?
|
| Clinical Competence | 1 | 2023 | 751 | 0.160 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 1621 | 0.160 |
Why?
|
| Health Personnel | 1 | 2020 | 202 | 0.150 |
Why?
|
| Value of Life | 1 | 2017 | 22 | 0.150 |
Why?
|
| Cerebral Ventricles | 1 | 2017 | 76 | 0.150 |
Why?
|
| Adolescent | 3 | 2023 | 8979 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2021 | 2767 | 0.150 |
Why?
|
| Fibrinolytic Agents | 3 | 2017 | 202 | 0.150 |
Why?
|
| ROC Curve | 2 | 2016 | 752 | 0.150 |
Why?
|
| Meningeal Neoplasms | 1 | 2017 | 61 | 0.140 |
Why?
|
| Meningioma | 1 | 2017 | 60 | 0.140 |
Why?
|
| Glasgow Outcome Scale | 1 | 2016 | 7 | 0.140 |
Why?
|
| Physician-Patient Relations | 1 | 2021 | 610 | 0.140 |
Why?
|
| Trauma Severity Indices | 1 | 2016 | 41 | 0.140 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2016 | 24 | 0.140 |
Why?
|
| Professional-Family Relations | 1 | 2016 | 48 | 0.140 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 373 | 0.130 |
Why?
|
| Data Display | 1 | 2015 | 24 | 0.130 |
Why?
|
| Texas | 1 | 2015 | 101 | 0.130 |
Why?
|
| Myocardium | 1 | 2018 | 529 | 0.130 |
Why?
|
| Incidence | 1 | 2020 | 1576 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 316 | 0.130 |
Why?
|
| Heart | 1 | 2018 | 539 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 301 | 0.130 |
Why?
|
| Palliative Care | 1 | 2017 | 257 | 0.130 |
Why?
|
| Area Under Curve | 1 | 2016 | 334 | 0.130 |
Why?
|
| Hospitalization | 1 | 2021 | 848 | 0.130 |
Why?
|
| Hydrocephalus | 1 | 2016 | 101 | 0.130 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2017 | 294 | 0.130 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2015 | 60 | 0.130 |
Why?
|
| Costs and Cost Analysis | 1 | 2015 | 153 | 0.130 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2015 | 53 | 0.130 |
Why?
|
| Child | 2 | 2023 | 6926 | 0.120 |
Why?
|
| Lung Diseases | 1 | 2016 | 263 | 0.120 |
Why?
|
| Biomarkers | 1 | 2021 | 1718 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2015 | 180 | 0.120 |
Why?
|
| Levofloxacin | 1 | 2013 | 7 | 0.120 |
Why?
|
| National Institute of Neurological Disorders and Stroke (U.S.) | 1 | 2013 | 1 | 0.120 |
Why?
|
| Quadriplegia | 1 | 2013 | 22 | 0.120 |
Why?
|
| Data Collection | 1 | 2015 | 372 | 0.120 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2705 | 0.120 |
Why?
|
| Prostatitis | 1 | 2013 | 13 | 0.120 |
Why?
|
| Cytokines | 1 | 2017 | 776 | 0.120 |
Why?
|
| Neurologic Examination | 1 | 2013 | 118 | 0.110 |
Why?
|
| Radiography | 1 | 2015 | 813 | 0.110 |
Why?
|
| Pancreatitis | 1 | 2013 | 87 | 0.110 |
Why?
|
| Calcium Channel Blockers | 1 | 2013 | 203 | 0.110 |
Why?
|
| Brain Hemorrhage, Traumatic | 1 | 2012 | 2 | 0.110 |
Why?
|
| Infusions, Intravenous | 1 | 2013 | 429 | 0.110 |
Why?
|
| South Carolina | 1 | 2011 | 3 | 0.110 |
Why?
|
| Infarction | 1 | 2012 | 26 | 0.110 |
Why?
|
| Logistic Models | 1 | 2016 | 1185 | 0.100 |
Why?
|
| Latin America | 2 | 2023 | 14 | 0.100 |
Why?
|
| Endovascular Procedures | 2 | 2012 | 218 | 0.100 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 197 | 0.100 |
Why?
|
| Pyridines | 1 | 2013 | 309 | 0.100 |
Why?
|
| Diuretics, Osmotic | 1 | 2011 | 2 | 0.100 |
Why?
|
| Precision Medicine | 1 | 2016 | 395 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 916 | 0.100 |
Why?
|
| Perfusion Imaging | 1 | 2011 | 50 | 0.100 |
Why?
|
| Health Status Indicators | 1 | 2011 | 105 | 0.100 |
Why?
|
| Thrombectomy | 1 | 2012 | 158 | 0.100 |
Why?
|
| Siblings | 1 | 2011 | 111 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2017 | 3352 | 0.100 |
Why?
|
| Animals | 2 | 2023 | 26581 | 0.100 |
Why?
|
| Myocardial Stunning | 1 | 2010 | 12 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2013 | 695 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2011 | 278 | 0.090 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2012 | 261 | 0.090 |
Why?
|
| Europe | 2 | 2021 | 309 | 0.090 |
Why?
|
| Puerperal Disorders | 1 | 2009 | 32 | 0.090 |
Why?
|
| Kidney Diseases | 1 | 2013 | 418 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 94 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 521 | 0.080 |
Why?
|
| Survival Rate | 1 | 2013 | 1860 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 1961 | 0.080 |
Why?
|
| Kidney Transplantation | 1 | 2015 | 849 | 0.080 |
Why?
|
| Anemia, Pernicious | 1 | 2008 | 2 | 0.080 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2008 | 7 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 746 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 567 | 0.080 |
Why?
|
| Clinical Protocols | 2 | 2020 | 156 | 0.080 |
Why?
|
| Nitrous Oxide | 1 | 2008 | 107 | 0.080 |
Why?
|
| Anesthetics, Inhalation | 1 | 2008 | 95 | 0.070 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2008 | 85 | 0.070 |
Why?
|
| Echocardiography | 1 | 2010 | 911 | 0.070 |
Why?
|
| Heart Ventricles | 1 | 2010 | 760 | 0.060 |
Why?
|
| Hypertension | 1 | 2013 | 1141 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2021 | 812 | 0.060 |
Why?
|
| Delphi Technique | 1 | 2023 | 80 | 0.060 |
Why?
|
| Reference Standards | 1 | 2023 | 159 | 0.060 |
Why?
|
| Consensus | 1 | 2023 | 335 | 0.050 |
Why?
|
| Brain Stem | 1 | 2022 | 165 | 0.050 |
Why?
|
| Head Injuries, Closed | 1 | 2020 | 11 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2002 | 116 | 0.050 |
Why?
|
| Hernia, Inguinal | 1 | 2002 | 67 | 0.050 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2021 | 172 | 0.050 |
Why?
|
| Pituitary-Adrenal System | 1 | 2020 | 64 | 0.050 |
Why?
|
| Heart Failure | 1 | 2010 | 1203 | 0.050 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2020 | 81 | 0.050 |
Why?
|
| Oceania | 1 | 2020 | 4 | 0.050 |
Why?
|
| Personnel Management | 1 | 2020 | 7 | 0.050 |
Why?
|
| Middle East | 1 | 2020 | 17 | 0.050 |
Why?
|
| Respiratory Therapy | 1 | 2020 | 14 | 0.050 |
Why?
|
| Asia | 1 | 2020 | 94 | 0.050 |
Why?
|
| Pharmacists | 1 | 2020 | 32 | 0.050 |
Why?
|
| Transportation of Patients | 1 | 2020 | 32 | 0.050 |
Why?
|
| Internationality | 1 | 2020 | 69 | 0.040 |
Why?
|
| North America | 1 | 2020 | 180 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 232 | 0.040 |
Why?
|
| Thyroid Gland | 1 | 2020 | 270 | 0.040 |
Why?
|
| Neurology | 1 | 2020 | 70 | 0.040 |
Why?
|
| Survivors | 1 | 2020 | 226 | 0.040 |
Why?
|
| Neurosurgery | 1 | 2020 | 84 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 108 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 298 | 0.040 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2021 | 466 | 0.040 |
Why?
|
| Inpatients | 1 | 2021 | 297 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2017 | 153 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2017 | 220 | 0.040 |
Why?
|
| Blindness, Cortical | 1 | 2017 | 8 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 379 | 0.040 |
Why?
|
| Sex Factors | 1 | 2020 | 1054 | 0.040 |
Why?
|
| Comorbidity | 1 | 2021 | 943 | 0.040 |
Why?
|
| Erythrocytes | 1 | 2017 | 255 | 0.040 |
Why?
|
| Leukocytes | 1 | 2017 | 202 | 0.040 |
Why?
|
| Craniotomy | 1 | 2017 | 88 | 0.040 |
Why?
|
| Disease Progression | 1 | 2021 | 1531 | 0.030 |
Why?
|
| Chicago | 1 | 2020 | 1379 | 0.030 |
Why?
|
| United States | 2 | 2022 | 6665 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 426 | 0.030 |
Why?
|
| Glucose | 1 | 2017 | 638 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 740 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 97 | 0.030 |
Why?
|
| Infarction, Anterior Cerebral Artery | 1 | 2012 | 1 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2013 | 596 | 0.030 |
Why?
|
| Muscle Weakness | 1 | 2012 | 61 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2013 | 678 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 297 | 0.020 |
Why?
|
| Internship and Residency | 1 | 2020 | 1004 | 0.020 |
Why?
|
| Medicine | 1 | 2011 | 89 | 0.020 |
Why?
|
| Medical Staff, Hospital | 1 | 2011 | 107 | 0.020 |
Why?
|
| Headache Disorders, Primary | 1 | 2009 | 3 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2009 | 135 | 0.020 |
Why?
|
| Analgesics | 1 | 2009 | 119 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1830 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2008 | 31 | 0.020 |
Why?
|
| Vitamin B 12 | 1 | 2008 | 24 | 0.020 |
Why?
|
| Leg | 1 | 2008 | 137 | 0.020 |
Why?
|
| Pregnancy | 1 | 2009 | 2893 | 0.010 |
Why?
|